---
title: "Strain-specific and HIV-driven humoral responses to Epstein-Barr virus mapped by PhIP-Seq"
id: "pubmed-42841646"
canonical_url: "https://medichelpline.com/clinical-feed/pubmed-42841646"
content_type: "clinical_feed_article"
specialty: "Infectious Disease"
source_name: "PubMed / NCBI"
source_url: "https://pubmed.ncbi.nlm.nih.gov/42841646/"
doi: "10.1128/jvi.01043-26"
published_at: "2026-11-17T00:00:00.000Z"
evidence_level: "Journal Article"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Strain-specific and HIV-driven humoral responses to Epstein-Barr virus mapped by PhIP-Seq
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/pubmed-42841646
- **Specialty:** [Infectious Disease](https://medichelpline.com/clinical-feed/infectious-disease.md)
- **Primary Source:** PubMed / NCBI
- **Source URL:** [Original Journal Publication](https://pubmed.ncbi.nlm.nih.gov/42841646/)
- **DOI:** [10.1128/jvi.01043-26](https://doi.org/10.1128%2Fjvi.01043-26)
- **Published At:** 2026-11-17T00:00:00.000Z
- **Evidence Rating:** Journal Article
## Executive GIST (TL;DR)
- The study used **PhIP-Seq** with the **VirScan** phage-display library to map antibody responses across the entire **Epstein-Barr virus** (EBV) proteome at peptide-level resolution. - The cohort comprised 115 adults from sub-Saharan Africa; the source reported 43 individuals with **HIV-1** and 72 without HIV-1. - Investigators identified **EBNA1**, **EBNA2**, **EBNA3B**, and capsid protein **BFRF3** as the most immunodominant EBV proteins across participants. - Antibody reactivities differed between EBV Type 1 and Type 2 specifically in **EBNA2**, with stronger recognition near the C-terminal transactivation domain (C-TAD) for Type 1. - A region of **EBNA1** that contains the nuclear localization sequence (NLS) emerged as the single most frequently targeted epitope in the EBV proteome. - People with HIV-1 (PWH) showed increased breadth and magnitude of antibody recognition against most EBV proteins compared with HIV-uninfected individuals, according to the data. - Authors interpreted these patterns as possibly reflecting higher EBV antigen exposure in PWH, likely from increased viral reactivation and HIV-associated immunologic effects. - The paper notes potential implications for EBV-associated cancer risk in PWH and calls for longitudinal work to evaluate whether altered humoral profiles may serve as prognostic biomarkers. - The source did not report longitudinal outcome data or specific biomarker performance metrics; it did not provide therapeutic dosing or interventional details because this was an observational seroprofiling study.
## Clinical Analysis & Structured Key Points
Clipboard, Search History, and several other advanced features are temporarily unavailable. [ Skip to main page content ](https://pubmed.ncbi.nlm.nih.gov/42841646/#article-details) ### NIH Websites Are Changing * [Get the Latest Updates and FAQs on the transition](https://www.nih.gov/web-modernization) * Per [Executive Order 14434](https://www.whitehouse.gov/presidential-actions/2026/09/inaugurating-the-era-of-super-intelligence/), federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition. ![U.S. flag](https://cdn.ncbi.nlm.nih.gov/coreutils/uswds/img/favicons/favicon-57.png) An official website of the United States government Here's how you know ![Dot gov](https://cdn.ncbi.nlm.nih.gov/coreutils/uswds/img/icon-dot-gov.svg) **The .gov means it’s official.** Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site. ![Https](https://cdn.ncbi.nlm.nih.gov/coreutils/uswds/img/icon-https.svg) **The site is secure.** The **https://** ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. [ ![NIH NLM Logo](https://cdn.ncbi.nlm.nih.gov/coreutils/nwds/img/logos/AgencyLogo.svg) ](https://www.ncbi.nlm.nih.gov/) [Log in](https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F42841646%2F) Show account info Close #### Account Logged in as: **username** * [Dashboard](https://www.ncbi.nlm.nih.gov/myncbi/) * [Publications](https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/) * [Account settings](https://www.ncbi.nlm.nih.gov/account/settings/) * [Log out](https://www.ncbi.nlm.nih.gov/account/signout/?back_url=https%3A//pubmed.ncbi.nlm.nih.gov/42841646/) [Access keys](https://www.ncbi.nlm.nih.gov/guide/browsers/#ncbi_accesskeys) [NCBI Homepage](https://www.ncbi.nlm.nih.gov) [MyNCBI Homepage](https://pubmed.ncbi.nlm.nih.gov/myncbi/) [Main Content](https://pubmed.ncbi.nlm.nih.gov/42841646/#maincontent) [Main Navigation](https://pubmed.ncbi.nlm.nih.gov/42841646/) [ ![pubmed logo](https://cdn.ncbi.nlm.nih.gov/pubmed/a447896c-976f-490b-b86b-2668b65114a8/core/images/pubmed-logo-blue.svg) ](https://pubmed.ncbi.nlm.nih.gov/) [ ](https://pubmed.ncbi.nlm.nih.gov/42841646/ "Show search bar") Search: [](https://pubmed.ncbi.nlm.nih.gov/42841646/ "Clear search input")Search [Advanced](https://pubmed.ncbi.nlm.nih.gov/advanced/) [ Clipboard ](https://pubmed.ncbi.nlm.nih.gov/clipboard/) [ User Guide ](https://pubmed.ncbi.nlm.nih.gov/help/) Save Email Send to * [ Clipboard ](https://pubmed.ncbi.nlm.nih.gov/42841646/) * [My Bibliography](https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F42841646%2F%23open-bibliography-panel) * [Collections](https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F42841646%2F%23open-collections-panel) * [Citation manager](https://pubmed.ncbi.nlm.nih.gov/42841646/) Display options Display options Format Abstract PubMed PMID ## Save citation to file Format: Summary (text) PubMed PMID Abstract (text) CSV Create file Cancel ## Email citation Email address has not been verified. Go to [ My NCBI account settings ](https://account.ncbi.nlm.nih.gov/settings/) to confirm your email and then refresh this page. To: Subject: Body: Format: Summary Summary (text) Abstract Abstract (text) MeSH and other data Send email Cancel ### Add to Collections * Create a new collection * Add to an existing collection Name your collection: Name must be less than 100 characters Choose a collection: Unable to load your collection due to an error [Please try again](https://pubmed.ncbi.nlm.nih.gov/42841646/) Add Cancel ### Add to My Bibliography * My Bibliography Unable to load your delegates due to an error [Please try again](https://pubmed.ncbi.nlm.nih.gov/42841646/) Add Cancel ## Your saved search Name of saved search: Search terms: [Test search terms](https://pubmed.ncbi.nlm.nih.gov/42841646/) Would you like email updates of new search results? Saved Search Alert Radio Buttons * Yes * No Email: ([change](https://www.ncbi.nlm.nih.gov/account/settings/)) Frequency: Monthly Weekly Daily Which day? The first Sunday The first Monday The first Tuesday The first Wednesday The first Thursday The first Friday The first Saturday The first day The first weekday Which day? Sunday Monday Tuesday Wednesday Thursday Friday Saturday Report format: Summary Summary (text) Abstract Abstract (text) PubMed Send at most: 1 item 5 items 10 items 20 items 50 items 100 items 200 items Send even when there aren't any new results Optional text in email: Save Cancel ## Create a file for external citation management software Create file Cancel ## Your RSS Feed Name of RSS Feed: Number of items displayed: 5 10 15 20 50 100 Create RSS Cancel RSS Link Copy ### Full text links [![Atypon full text link](https://cdn.ncbi.nlm.nih.gov/corehtml/query/egifs/https:--journals.asm.org-pb-assets-pubmed-pubmed_ASMJ_OA.png) Atypon ](https://journals.asm.org/doi/10.1128/jvi.01043-26?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed "See full text options at Atypon") [ Full text links ](https://pubmed.ncbi.nlm.nih.gov/42841646/) ### Actions Cite Collections Add to Collections * Create a new collection * Add to an existing collection Name your collection: Name must be less than 100 characters Choose a collection: Unable to load your collection due to an error [Please try again](https://pubmed.ncbi.nlm.nih.gov/42841646/) Add Cancel Permalink Permalink Copy Display options Display options Format Abstract PubMed PMID ### Experimental Resource Linked Discoveries ### Page navigation * [ Title & authors ](https://pubmed.ncbi.nlm.nih.gov/42841646/#heading) * [ Abstract ](https://pubmed.ncbi.nlm.nih.gov/42841646/#abstract) * [ Conflict of interest statement ](https://pubmed.ncbi.nlm.nih.gov/42841646/#conflict-of-interest) * [Similar articles](https://pubmed.ncbi.nlm.nih.gov/42841646/#similar) * [ MeSH terms ](https://pubmed.ncbi.nlm.nih.gov/42841646/#mesh-terms) * [ Substances ](https://pubmed.ncbi.nlm.nih.gov/42841646/#substances) * [Related information](https://pubmed.ncbi.nlm.nih.gov/42841646/#related-links) * [ Grants and funding ](https://pubmed.ncbi.nlm.nih.gov/42841646/#grants) * [ LinkOut - more resources ](https://pubmed.ncbi.nlm.nih.gov/42841646/#linkout) Title & authors Abstract Conflict of interest statement Similar articles MeSH terms Substances Related information Grants and funding LinkOut - more resources J Virol Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22J+Virol%22%5Bjour%5D&sort=date&sort_order=desc) * [ Search in NLM Catalog ](https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22J+Virol%22%5BTitle+Abbreviation%5D) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42841646/) . 2026 Nov 17;100(11):e0104326. doi: 10.1128/jvi.01043-26. Epub 2026 Oct 7. # Humoral response against Epstein-Barr virus follows a strain-specific and HIV-driven pattern [Eric D Eymard](https://pubmed.ncbi.nlm.nih.gov/?term=Eymard+ED&cauthor_id=42841646)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/42841646/#full-view-affiliation-1 "Department of Interdisciplinary Oncology, Louisiana State University Health Sciences Center, New Orleans, Louisiana, USA."), [Dicle Yalcin](https://pubmed.ncbi.nlm.nih.gov/?term=Yalcin+D&cauthor_id=42841646)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/42841646/#full-view-affiliation-1 "Department of Interdisciplinary Oncology, Louisiana State University Health Sciences Center, New Orleans, Louisiana, USA."), [Owen Ngalamika](https://pubmed.ncbi.nlm.nih.gov/?term=Ngalamika+O&cauthor_id=42841646)[ 2 ](https://pubmed.ncbi.nlm.nih.gov/42841646/#full-view-affiliation-2 "Dermatology and Venereology Section, University Teaching Hospital, University of Zambia School of Medicine, Lusaka, Zambia."), [Salum J Lidenge](https://pubmed.ncbi.nlm.nih.gov/?term=Lidenge+SJ&cauthor_id=42841646)[ 3 ](https://pubmed.ncbi.nlm.nih.gov/42841646/#full-view-affiliation-3 "Ocean Road Cancer Institute, Dar es Salaam, Tanzania.")[ 4 ](https://pubmed.ncbi.nlm.nih.gov/42841646/#full-view-affiliation-4 "Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania."), [John T West](https://pubmed.ncbi.nlm.nih.gov/?term=West+JT&cauthor_id=42841646)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/42841646/#full-view-affiliation-1 "Department of Interdisciplinary Oncology, Louisiana State University Health Sciences Center, New Orleans, Louisiana, USA."), [Charles Wood](https://pubmed.ncbi.nlm.nih.gov/?term=Wood+C&cauthor_id=42841646)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/42841646/#full-view-affiliation-1 "Department of Interdisciplinary Oncology, Louisiana State University Health Sciences Center, New Orleans, Louisiana, USA.") Affiliations Expand ### Affiliations * 1 Department of Interdisciplinary Oncology, Louisiana State University Health Sciences Center, New Orleans, Louisiana, USA. * 2 Dermatology and Venereology Section, University Teaching Hospital, University of Zambia School of Medicine, Lusaka, Zambia. * 3 Ocean Road Cancer Institute, Dar es Salaam, Tanzania. * 4 Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania. * PMID: **42841646** * DOI: [ 10.1128/jvi.01043-26 ](https://doi.org/10.1128/jvi.01043-26) Free article Item in Clipboard # Humoral response against Epstein-Barr virus follows a strain-specific and HIV-driven pattern Eric D Eymard et al. J Virol. 2026. Free article Show details Display options Display options Format Abstract PubMed PMID J Virol Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22J+Virol%22%5Bjour%5D&sort=date&sort_order=desc) * [ Search in NLM Catalog ](https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22J+Virol%22%5BTitle+Abbreviation%5D) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42841646/) . 2026 Nov 17;100(11):e0104326. doi: 10.1128/jvi.01043-26. Epub 2026 Oct 7. ### Authors [Eric D Eymard](https://pubmed.ncbi.nlm.nih.gov/?term=Eymard+ED&cauthor_id=42841646)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/42841646/#short-view-affiliation-1 "Department of Interdisciplinary Oncology, Louisiana State University Health Sciences Center, New Orleans, Louisiana, USA."), [Dicle Yalcin](https://pubmed.ncbi.nlm.nih.gov/?term=Yalcin+D&cauthor_id=42841646)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/42841646/#short-view-affiliation-1 "Department of Interdisciplinary Oncology, Louisiana State University Health Sciences Center, New Orleans, Louisiana, USA."), [Owen Ngalamika](https://pubmed.ncbi.nlm.nih.gov/?term=Ngalamika+O&cauthor_id=42841646)[ 2 ](https://pubmed.ncbi.nlm.nih.gov/42841646/#short-view-affiliation-2 "Dermatology and Venereology Section, University Teaching Hospital, University of Zambia School of Medicine, Lusaka, Zambia."), [Salum J Lidenge](https://pubmed.ncbi.nlm.nih.gov/?term=Lidenge+SJ&cauthor_id=42841646)[ 3 ](https://pubmed.ncbi.nlm.nih.gov/42841646/#short-view-affiliation-3 "Ocean Road Cancer Institute, Dar es Salaam, Tanzania.")[ 4 ](https://pubmed.ncbi.nlm.nih.gov/42841646/#short-view-affiliation-4 "Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania."), [John T West](https://pubmed.ncbi.nlm.nih.gov/?term=West+JT&cauthor_id=42841646)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/42841646/#short-view-affiliation-1 "Department of Interdisciplinary Oncology, Louisiana State University Health Sciences Center, New Orleans, Louisiana, USA."), [Charles Wood](https://pubmed.ncbi.nlm.nih.gov/?term=Wood+C&cauthor_id=42841646)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/42841646/#short-view-affiliation-1 "Department of Interdisciplinary Oncology, Louisiana State University Health Sciences Center, New Orleans, Louisiana, USA.") ### Affiliations * 1 Department of Interdisciplinary Oncology, Louisiana State University Health Sciences Center, New Orleans, Louisiana, USA. * 2 Dermatology and Venereology Section, University Teaching Hospital, University of Zambia School of Medicine, Lusaka, Zambia. * 3 Ocean Road Cancer Institute, Dar es Salaam, Tanzania. * 4 Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania. * PMID: **42841646** * DOI: [ 10.1128/jvi.01043-26 ](https://doi.org/10.1128/jvi.01043-26) Item in Clipboard Full text links Cite Display options Display options Format Abstract PubMed PMID Linked Discoveries ## Abstract Epstein-Barr virus (EBV) is a ubiquitous human gammaherpesvirus causally linked to several malignancies, including lymphomas and solid tumors. Despite its high global prevalence, a comprehensive profile of humoral responses to EBV is yet to be described. Moreover, how HIV-1 co-infection influences this response can reveal new insights into how cancer risk increases in people with HIV-1 (PWH). Here, we employed phage immunoprecipitation and sequencing (PhIP-Seq) using the VirScan phage-display library to map antibody responses against the EBV proteome in 115 adults from sub-Saharan Africa, with and without HIV-1 co-infection (43 HIV-positive and 72 HIV-negative) at peptide-level resolution. We identified EBNA1, EBNA2, EBNA3B, and the viral capsid antigen protein BFRF3 as the most immunodominant EBV proteins. Differential antibody reactivities between EBV Type 1 and Type 2 were observed against EBNA2, with increased antibody recognition near the C-terminal transactivation domain (C-TAD) observed for Type 1. A specific region of EBNA1 containing the nuclear localization sequence (NLS) was the most frequently targeted epitope of the EBV proteome. Our comprehensive and high-resolution analysis identified several immunodominant EBV proteins that are targeted by most individuals regardless of HIV-1 status. HIV-1 co-infected individuals (PWH) had increased antibody recognition against most EBV proteins compared to HIV-uninfected individuals, but the magnitudes of those responses varied across the proteome. Overall, our findings suggest that HIV-1 co-infection alters both the breadth and magnitude of anti-EBV responses, potentially reflecting increased viral reactivation and HIV-driven mechanisms of immunosuppression that may impact the magnitude of antibody responses in EBV.IMPORTANCEThis study employs the first comprehensive high-resolution antibody profiling against Epstein-Barr virus (EBV) among healthy adults and people with HIV-1 (PWH). Our results indicated that HIV-1 has a considerable influence on the anti-EBV repertoire that may provide further evidence of how HIV-1 significantly increases the risk of EBV-associated malignancies such as lymphoma. We showed evidence that HIV-1 co-infection leads to higher exposure to viral antigens, likely due to viral reactivation, reflected by a higher percentage of patients with antibodies reactive to the majority of EBV proteins when compared to people without HIV-1. Since PWH are known to be more susceptible to EBV-associated cancers, whether these changes in humoral immune response can be used as prognostic biomarkers for cancer risks should be further investigated with longitudinal studies. **Keywords:** Epstein-Barr virus; PhIP-Seq; VirScan; human immunodeficiency virus; humoral immunity; latent infection; oncogenic virus. [PubMed Disclaimer](https://pubmed.ncbi.nlm.nih.gov/disclaimer/) ## Conflict of interest statement The authors declare no conflict of interest. ## Similar articles * [ Association between Antibody Responses to Epstein-Barr Virus Glycoproteins, Neutralization of Infectivity, and the Risk of Nasopharyngeal Carcinoma. ](https://pubmed.ncbi.nlm.nih.gov/33268566/) Zhu QY, Kong XW, Sun C, Xie SH, Hildesheim A, Cao SM, Zeng MS.Zhu QY, et al.mSphere. 2020 Dec 2;5(6):e00901-20. doi: 10.1128/mSphere.00901-20.mSphere. 2020.PMID: 33268566Free PMC article. * [ Epstein-Barr virus nuclear antigen 2 transactivates the long terminal repeat of human immunodeficiency virus type 1. ](https://pubmed.ncbi.nlm.nih.gov/8386279/) Scala G, Quinto I, Ruocco MR, Mallardo M, Ambrosino C, Squitieri B, Tassone P, Venuta S.Scala G, et al.J Virol. 1993 May;67(5):2853-61. doi: 10.1128/JVI.67.5.2853-2861.1993.J Virol. 1993.PMID: 8386279Free PMC article. * [ Humoral response to Epstein-Barr virus in patients with multiple sclerosis treated with B cell depletion therapy. ](https://pubmed.ncbi.nlm.nih.gov/37804765/) Rød BE, Wergeland S, Bjørnevik K, Holmøy T, Ulvestad E, Njølstad G, Myhr KM, Torkildsen Ø.Rød BE, et al.Mult Scler Relat Disord. 2023 Nov;79:105037. doi: 10.1016/j.msard.2023.105037. Epub 2023 Sep 30.Mult Scler Relat Disord. 2023.PMID: 37804765Clinical Trial. * [ Epstein-Barr Virus-Specific Humoral Immune Responses in Health and Disease. ](https://pubmed.ncbi.nlm.nih.gov/26428379/) Middeldorp JM.Middeldorp JM.Curr Top Microbiol Immunol. 2015;391:289-323. doi: 10.1007/978-3-319-22834-1_10.Curr Top Microbiol Immunol. 2015.PMID: 26428379Review. * [ Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. ](https://pubmed.ncbi.nlm.nih.gov/36321557/) Crider K, Williams J, Qi YP, Gutman J, Yeung L, Mai C, Finkelstain J, Mehta S, Pons-Duran C, Menéndez C, Moraleda C, Rogers L, Daniels K, Green P.Crider K, et al.Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.Cochrane Database Syst Rev. 2022.Update in: [Cochrane Database Syst Rev. 2026 Feb 18;2:CD014217. doi: 10.1002/14651858.CD014217.pub2.](https://pubmed.ncbi.nlm.nih.gov/41705996/)PMID: 36321557Free PMC article.Updated. [ See all similar articles ](https://pubmed.ncbi.nlm.nih.gov/?linkname=pubmed_pubmed&from_uid=42841646) ## MeSH terms * Adult Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Adult%22%5BMeSH%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Adult) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42841646/) * Antibodies, Viral* / blood Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Antibodies%2C+Viral%2Fblood%22%5BMAJR%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Antibodies%2C+Viral) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42841646/) * Antibodies, Viral* / immunology Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Antibodies%2C+Viral%2Fimmunology%22%5BMAJR%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Antibodies%2C+Viral) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42841646/) * Antigens, Viral / immunology Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Antigens%2C+Viral%2Fimmunology%22%5BMeSH%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Antigens%2C+Viral) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42841646/) * Coinfection / immunology Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Coinfection%2Fimmunology%22%5BMeSH%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Coinfection) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42841646/) * Coinfection / virology Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Coinfection%2Fvirology%22%5BMeSH%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Coinfection) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42841646/) * Epstein-Barr Virus Infections* / immunology Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Epstein-Barr+Virus+Infections%2Fimmunology%22%5BMA
## Related Clinical Research

- [Herpesvirus–autoantigen antibody networks linked to chronic disease in large biobank profiling](https://medichelpline.com/clinical-feed/nature-immunology-2-large-scale-antibody-reactome-profiling-identifies-herpesvirus-autoantigen.md)
- [Herpesvirus Antibody Networks Linked to Autoimmunity and Chronic Disease](https://medichelpline.com/clinical-feed/nature-immunology-0-herpesvirus-exposures-map-to-self-reactivity-networks-in-chronic-disease.md)
- [Cell Therapy's Role in Humoral Alloimmunity Post-Transplantation](https://medichelpline.com/clinical-feed/frontiers-in-immunology-11-cell-therapy-and-humoral-alloimmunity-post-transplantation-a-review-of.md)
- [Age-specific contact matrices across 28 EU/EEA countries during COVID-19: linking NPIs to social m](https://medichelpline.com/clinical-feed/medrxiv-21-reconstructing-age-specific-social-contact-patterns-across-28-eu-eea-countries.md)
- [CBC-derived three-parameter score predicts dengue NS1 antigen positivity in Dhaka cohort](https://medichelpline.com/clinical-feed/medrxiv-22-a-cbc-derived-score-associated-with-dengue-ns1-antigen-positivity-among.md)

## Navigation
- [← Back to Infectious Disease Feed](https://medichelpline.com/clinical-feed/infectious-disease.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.